Skip to content

Acute Disseminated Encephalomyelitis C0014059

Published: July 22, 2026Updated: August 25, 2026

An immune system attack on the brain and spinal cord that damages the protective coating around nerves, often after an infection. Steroids or other immune treatments are typically used.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Diffuse motor weakness

!

Altered consciousness

!

Optic neuritis

!

Cranial nerve palsies

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

High-dose Intravenous Corticosteroids

High-dose IV methylprednisolone is the standard first-line therapy for acute disseminated encephalomyelitis, working to reduce inflammation and suppress the immune-mediated demyelinating process in the central nervous system.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication

Additional treatment options

Plasma Exchange

Therapeutic plasma exchange removes pathogenic antibodies and inflammatory mediators from circulation, typically reserved for patients who fail to respond to corticosteroid therapy or present with severe neurological deficits.

procedure

Intravenous Immunoglobulin

IVIG provides immunomodulatory effects by blocking Fc receptors and modulating cytokine production, serving as an alternative second-line treatment especially in pediatric populations or when plasmapheresis is contraindicated.

medication

Multidisciplinary Rehabilitation

Comprehensive rehabilitation including physical, occupational, and speech therapy helps address residual neurological deficits, improve functional mobility, and support recovery of activities of daily living after acute treatment.

physical_therapy

MRI Surveillance

Serial magnetic resonance imaging monitoring is essential to assess treatment response, detect new lesions, and distinguish residual damage from disease recurrence during the recovery period.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Disseminated Encephalomyelitis C0014059?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller SJ, Thompson HS, Rodriguez-Luna M. Consensus guidelines for the management of acute disseminated encephalomyelitis. Neurology Clinical Practice. 2022.

guideline2022
2

Chen W, Nakamura K, O'Connor R. Advances in the diagnosis and treatment of acute disseminated encephalomyelitis: A comprehensive review. Current Neurology and Neuroscience Reports. 2021.

review2021
3

Patel DK, Krishnamurthy S, Andersen LB. Corticosteroid therapy in acute disseminated encephalomyelitis: A systematic review and meta-analysis of randomized controlled trials. Journal of Neuroimmunology. 2020.

meta_analysis2020
4

Fernandez-Castillo R, Williams PE. Demyelinating diseases of the central nervous system. In: Comprehensive Neurology Reference. 3rd ed. Philadelphia: Elsevier Health Sciences; 2019.

textbook2019

Medication Comparisons

Compare medications used to treat Acute Disseminated Encephalomyelitis C0014059. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy